Akorn Inc. (AKRX) announced after the bell Monday that the company and Fresenius Kabi AG, with the assistance of outside consultants, are investigating alleged breaches of FDA data integrity requirements relating to product development at the company.
from RTT - Before the Bell http://ift.tt/2Cqeh4G
via IFTTT
No comments:
Post a Comment